phase 1_2_completion
saveBellicum Pharmaceuticals Inc — acetaminophen (Phase I/II Trial Completion)
community read0 votes
Therapy area: Oncology. Indication: Breast Cancer, Lung Cancer, Malignant Mesothelioma, Malignant Pleural Mesothelioma, Metastatic Breast Cancer, Non-Small Cell Lung Cancer
Data sources
globaldata
Found something off?
drug timeline · 8
- phase 2 completionPolice General Hospital — acetaminophen (Phase II Trial Completion)Apr 30, 2026 · 165d ago
- phase 1 completionMassachusetts General Hospital — acetaminophen (Phase I Trial Completion)Apr 30, 2026 · 165d ago
- phase 1 completionJiangsu Postgraduate Research and Practice Innovation Program — acetaminophen (Phase I Trial Completion)Apr 30, 2026 · 165d ago
- phase 2 completionAssaf Harofeh Medical Center — acetaminophen (Phase II Trial Completion)Apr 30, 2026 · 165d ago
- phase 2 3 initiationPostgraduate Institute of Medical Education and Research — acetaminophen (Phase II/III Trial Initiation)Apr 24, 2026 · 171d ago
- approvalHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalDec 31, 2025 · 285d ago
- approvalHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalDec 31, 2025 · 285d ago
- approvalHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalDec 31, 2025 · 285d ago
comments(0)
5-min edit window · permanent after that